Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

108.97 -2.51 (-2.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biontech Se ADR

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
64 65 Next >
Disney Leads Media Earnings This Week As Reporting Season Moves Past The Peak
We are past the peak of earnings season, and about 87% of the S&P 500 companies have already released their quarterly numbers, FactSet reports. 
Via Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Genmab, BioNTech Join Forces For Cancer Immunotherapy Candidates
Via Benzinga
A Flurry Of Employment News Drops Ahead Of Friday's Jobs Report
(Thursday Market Open) The Bank of England (BoE) raised its key lending rate by 50 basis points, its biggest hike in 27 years. 
Via Benzinga
Analyst Ratings for BioNTech
Analysts have provided the following ratings for BioNTech (NASDAQ:BNTX) within the last quarter: 
Via Benzinga
Here's Why BioNTech Stock Is Moving
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher in sympathy with Moderna Inc (NASDAQ: MRNA), which reported better-than-expected second-quarter results. 
Via Benzinga
Equity Index Futures Rebound Despite Concerns Over OPEC And China
(Wednesday Market Open) Stocks look to rebound as equity index futures point to a higher open and the dollar retreats from yesterday’s rally. But Fed speak and news out of OPEC and China present... 
Via Benzinga
BioNTech Earnings Conference Call Is Coming Up, Here's What You Need To Know
BioNTech (NASDAQ:BNTX) will host a conference call at 08:00 AM ET on August 8, 2022, to discuss Q2 2022 earnings results. How to Attend BioNTech (BNTX) Conference Call Follow this link to access the... 
Via Benzinga
U.S. Manufacturing Picture Is Looking Brighter Than Europe's Right Now
(Tuesday Market Open) Global jitters over U.S. House Speaker Nancy Pelosi’s expected visit to Taiwan dominated premarket trading with major U.S. equities indexes moving mildly lower before the open.... 
Via Benzinga
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care... 
Via Benzinga
5 Value Stocks In The Healthcare Sector
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
Is The Energy Ready To Rebound?
(Monday Market Open) Equity index futures turned a bit negative to start a new week and month, as investors are still digesting last week’s data with the S&P 500® index (SPX) near June highs. 
Via Benzinga
Pfizer Ticks Higher As Covid Vaccine, Pill Carry Its Second-Quarter Beat
The company projects strong sales of Comirnaty and Paxlovid in 2022. 
Via Investor's Business Daily
Is Moderna's Cheaper Valuation A Buying Signal?
Moderna is one of the least expensive companies in the S&P 500 in terms of valuation. In this article, we'll examine other aspects of the company. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Pfizer/BioNTech Start Ohase 2 Trial For COVID-19 Vaccine Against Omicron Subvariant
Via Benzinga
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
From BioNTech SE
Via GlobeNewswire
BioNTech, Pfizer File For Clearance Over COVID-19 Vaccine Patent Dispute With CureVac
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
What is a Value Stock? 
Via Benzinga
WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years
Via Benzinga
Why BioNTech Is Trading Higher Today Following A Stock Upgrade From SVB Securities Analyst
SVB Securities, a division of SVB Financial Group (NASDAQ: SIVB), believes BioNTech SE – ADR (NASDAQ: BNTX) stock is trading below the most negative scenario for the COVID-19 vaccine mar 
Via Benzinga
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
Via Benzinga
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On Upgrade
BioNTech won an upgrade Wednesday. Here's what one analyst expects to drive growth. 
Via Investor's Business Daily
AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, In Expert Review
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
Upgrades 
Via Benzinga
Benzinga Before The Bell: Most Effective Covid-19 Vaccine, Google's Hiring Slowdown, Panasonic's New EV Battery And Other Top Financial Stories Wednesday, July 13
CNBC Bankrupt Crypto Firm Three Arrows Capital’s Assets Frozen By New York Judge 
Via Benzinga
Amazon.com To $145? Here's The Biggest Price Target Changes For Wednesday
SVB Leerink cut BioNTech SE (NASDAQ: BNTX) price target from $253 to $223. BioNTech shares rose 2.1% to $164.77 in pre-market trading. 
Via Benzinga
Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out
Via Benzinga
U.S. Stock Futures Higher; All Eyes On Inflation Data
Pre-open movers 
Via Benzinga
The Good News For Moderna's Covid Shot Barely Moved Its Stock
Moderna stock reacted minimally to positive results for its updated Covid booster. 
Via Investor's Business Daily
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
64 65 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.